Rossi, E.; Cellini, F.; Pagliara, M.M.; Sammarco, M.G.; Pedone, R.R.; Lancellotta, V.; Tagliaferri, L.; Quirino, M.; Gambacorta, M.A.; Blasi, M.A.;
et al. Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients. Cancers 2023, 15, 493.
https://doi.org/10.3390/cancers15020493
AMA Style
Rossi E, Cellini F, Pagliara MM, Sammarco MG, Pedone RR, Lancellotta V, Tagliaferri L, Quirino M, Gambacorta MA, Blasi MA,
et al. Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients. Cancers. 2023; 15(2):493.
https://doi.org/10.3390/cancers15020493
Chicago/Turabian Style
Rossi, Ernesto, Francesco Cellini, Monica Maria Pagliara, Maria Grazia Sammarco, Romina Rose Pedone, Valentina Lancellotta, Luca Tagliaferri, Michela Quirino, Maria Antonietta Gambacorta, Maria Antonietta Blasi,
and et al. 2023. "Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients" Cancers 15, no. 2: 493.
https://doi.org/10.3390/cancers15020493
APA Style
Rossi, E., Cellini, F., Pagliara, M. M., Sammarco, M. G., Pedone, R. R., Lancellotta, V., Tagliaferri, L., Quirino, M., Gambacorta, M. A., Blasi, M. A., Tortora, G., & Schinzari, G.
(2023). Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients. Cancers, 15(2), 493.
https://doi.org/10.3390/cancers15020493
